The ABI3 immunoreactivity was barely detectable in the brains of cognitively normal human; however, ABI3 was preferentially expressed in activated microglia in close proximity to Aβ plaques in AD patients (Satoh et al., 2017; Karahan et al., 2021). This evidence concerns the gene ABI3 and Alzheimer disease.